MARC SE-Africa took the stage at the East Africa Community (EAC) Great Lakes Malaria Initiative (GLMI) coordination meeting in the United Republic of Tanzania. Stakeholders from across the region strategized and collaborated on efforts to control malaria, with a focus on cross-border areas.

MARC SE-Africa and the University of Oxford’s Worldwide Antimalarial Resistance Network launched the Correlation between Kelch13 and Clinical Phenotype Study Group to advance our understanding of malaria resistance.

Listen to the podcast “An Old Killer, Malaria, Learns New Tricks”, in which Prof Karen Barnes explains the problem and possible solutions to One Health Trust.

The MARC SE-Africa consortium is all about collaboration and works to respond to the growing crisis in malaria by better defining the extent of antimalarial resistance in Southeast Africa and expediting the sharing of such evidence with National Malaria Programmes and their implementation partners.

The WHO's Meeting on Antimalarial Resistance held in November in Kampala, Uganda. MARC SE-Africa has been represented by Stephanie van Wyk, Elias Phiri, Joaniter Nankabirwa, Donnie Mategula, and Rhona Mijumbi.

The RBM Partnership To End Malaria. Case Management Working Group held its 12th annual meeting in Accra, Ghana from 22 to 25 August 2023, where MARC SE-Africa was represented by Donnie Mategula (Malawi) and Karen Barnes (Coordinator).

The imminent threat of artemisinin resistance prompted a group of emerging and established researchers from Uganda, Malawi, Ethiopia and South Africa to get together for the MARC SE-Africa Writers’ Retreat in Cape Town (14-18 August 2023) to fast track their ongoing work to tackle this issue in Africa.

The MARC SE-Africa team members convened in Zanzibar in May 2023 for a first in-person meeting to discuss project activities over the coming four years.

The University of Cape Town (UCT) announced today the launch of MARC SE-Africa (Mitigating Antimalarial Resistance Consortium in Southern and East Africa). Over the next 4 years, MARC SE-Africa will receive almost 4.2 million Euro from the Global Health EDCTP3 Joint Undertaking established under the European Unions’ research and innovation programme, Horizon Europe.